GE HealthCare Technologies Inc.

Equities

GEHC

US36266G1076

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 16:00:00 2024-07-16 EDT			5-day change	1st Jan Change
82.64 ^USD	+3.06%		+7.51%	+6.88%

11:36am	BNP Paribas Exane Initiates GE HealthCare Technologies at Outperform With $92 Price Target	MT
07-10	Goldman Sachs Adjusts Price Target on GE HealthCare Technologies to $83 From $87	MT

GE HealthCare Technologies Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022

January 30, 2023 at 06:20 am

GE HealthCare Technologies Inc. reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported revenue was USD 4,938 million compared to USD 4,589 million a year ago. Net income was USD 554 million compared to USD 564 million a year ago.
For the full year, revenue was USD 18,341 million compared to USD 17,585 million a year ago. Net income was USD 1,916 million compared to USD 2,247 million a year ago.

Latest news about GE HealthCare Technologies Inc.

BNP Paribas Exane Initiates GE HealthCare Technologies at Outperform With $92 Price Target	05:36am	MT
Goldman Sachs Adjusts Price Target on GE HealthCare Technologies to $83 From $87	07-10	MT
3M CFO Patolawala to leave company at end of July	07-10	RE
UBS Adjusts Price Target on GE HealthCare Technologies to $84 From $88, Maintains Neutral Rating	07-02	MT
GE HealthCare Technologies Inc.(NasdaqGS:GEHC) dropped from Russell Top 200 Growth Index	06-30	CI
GE HealthCare Technologies Inc.(NasdaqGS:GEHC) dropped from Russell Top 200 Value Index	06-30	CI
GE HealthCare Technologies Inc.(NasdaqGS:GEHC) dropped from Russell Top 200 Index	06-30	CI
GE HealthCare Technologies Inc.(NasdaqGS:GEHC) added to Russell Midcap Growth Index	06-30	CI
GE HealthCare Technologies Inc.(NasdaqGS:GEHC) added to Russell Midcap Index	06-30	CI
GE HealthCare Technologies Inc.(NasdaqGS:GEHC) added to Russell Midcap Value Index	06-30	CI
GE HealthCare Technologies Keeps Quarterly Dividend at $0.03 Per Share, Payable Aug. 15 to Shareholders of Record on July 19	06-26	MT
GE HealthCare Technologies Inc. Announces Cash Dividend for Second Quarter of 2024, Payable on August 15, 2024	06-26	CI
GE HealthCare Partners With New Mexico Hospital to Install Allia IGS Pulse Electrophysiology Lab	06-24	MT
GE HealthCare, MediView Report Clinical Use of OmnifyXR Interventional Suite	06-20	MT
GE Healthcare and Mediview Announce the World's First Installation and Clinical Use of Augmented Reality Interventional Suite That Aims to Transform the Practice of Interventional Radiology	06-20	CI
GE HealthCare Reports Changes in Key Segments	06-10	MT
GE Healthcare Technologies Inc. Announces Management Changes	06-10	CI
Transcript : GE HealthCare Technologies Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 10:00 AM	06-05
Nucleus RadioPharma, Inc. announced that it has received $66.099956 million in funding from a group of investors	06-04	CI
GE HealthCare, Tampa General Hospital Expand Collaboration in Imaging, Ultrasound Technology	05-30	MT
GE Healthcare and Tampa General Hospital Expand Long-Term Partnership to Benefit Patients and Clinicians Across the State of Florida	05-30	CI
Goldman Sachs Initiates GE HealthCare Technologies With Neutral Rating, $87 Price Target	05-30	MT
GE Healthcare Names Adam Holton as Chief People Officer	05-29	CI
Some of the biggest splits in Corporate America	05-23	RE
GE HealthCare Technologies Insider Sold Shares Worth $7,109,427, According to a Recent SEC Filing	05-16	MT

Chart GE HealthCare Technologies Inc.

Duration

Period

More charts

Company Profile

GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. It develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment portfolio is comprised of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment is comprised of two business lines: contrast media and molecular imaging.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-07-31 - Q2 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for GE HealthCare Technologies Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

82.64 USD

Average target price

92.52 USD

Spread / Average Target

+11.96%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
GE HEALTHCARE TECHNOLOGIES INC.	+6.88%	37.72B
THERMO FISHER SCIENTIFIC	+4.64%	212B
DANAHER CORPORATION	+8.99%	187B
INTUITIVE SURGICAL, INC.	+29.83%	155B
BOSTON SCIENTIFIC CORPORATION	+35.17%	115B
SIEMENS HEALTHINEERS AG	+1.44%	65.5B
EDWARDS LIFESCIENCES CORPORATION	+15.06%	52.87B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-6.47%	45.25B
AGILENT TECHNOLOGIES, INC.	-2.14%	39.7B
RESMED, INC.	+20.22%	30.38B

Other Advanced Medical Equipment & Technology